Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial.
Lenz HJ, Liu T, Chen EY, Horváth Z, Bondarenko I, Danielewicz I, Ghidini M, García-Alfonso P, Jones R, Aapro M, Zhang Y, Wang J, Wang W, Adeleye J, Beelen A, Hubbard J.
Lenz HJ, et al. Among authors: beelen a.
JNCI Cancer Spectr. 2024 Nov 23:pkae116. doi: 10.1093/jncics/pkae116. Online ahead of print.
JNCI Cancer Spectr. 2024.
PMID: 39579142